1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Gilteritinib
Trade Name:
Xospata
Manufacturer/Distributor:
Astellas Pharma Canada
Classification:
Antineoplastic agent
ATC Class:
L01XE54 - gilteritinib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/12/23
Date Marketed in Canada (yyyy/mm/dd):
2020/02/03
Presentation:
Tablet: 40 mg. DIN: 02495058
Comments:
Used for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia with a FMS-like tyrosine kinase mutation.
Back to:
Drug Product Listings 
